Olmesartan Medoxomil-hydrochlorothiazide Tablet, Film Coated
Product Images NDC 42291-926

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil-hydrochlorothiazide (NDC 42291-926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

90 (924 90)

Label for Olmesartan Medoxomil and Hydrochlorothiazide Tablets 20 mg/12.5 mg by AvKARE. The label shows a package containing 90 film-coated tablets for oral use, including dosage information and storage instructions.*

FDA Label Image

90 (925 90)

Label for Olmesartan Medoxomil and Hydrochlorothiazide tablets, film-coated oral tablets, strength 40 mg/12.5 mg. The label shows the AvKARE brand, package contains 90 tablets, Rx only, with dosage and storage instructions and manufacturer details from AvKARE in Pulaski, TN.*

FDA Label Image

90 (926 90)

Label for olmesartan medoxomil and hydrochlorothiazide tablets, 40 mg/25 mg, film-coated oral tablets. The label indicates a package size of 90 tablets and is marked Rx Only. The labeler is AvKARE. Additional details include storage instructions and a QR code.*

FDA Label Image

Structural Formula (Benicar Hct 01)

Chemical structure diagram of olmesartan medoxomil-hydrochlorothiazide, showing the molecular arrangement of its components.*

FDA Label Image

Hctz Structure (Benicar Hct 02)

Chemical structure diagram depicting the molecular structure of olmesartan medoxomil-hydrochlorothiazide, showing various atoms and bonds typical of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.